OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000JC2QHM8

Real-time Bid/Ask 06:46:09 2024-05-24 EDT
3.11 EUR / 3.12 EUR -3.26% Intraday chart for OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-0.62%
1 month+0.31%
Date Price Change
24-05-24 3.18 -1.24%
24-05-23 3.22 +0.63%
24-05-22 3.2 +2.56%
24-05-21 3.12 +2.97%
24-05-20 3.03 -0.33%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 04:12 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer J.P. Morgan
WKN JC2QHM
ISINDE000JC2QHM8
Date issued 2020-06-22
Strike 70.68
Maturity Unlimited
Parity 10 : 1
Emission price 0.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.72
Lowest since issue 0.6
Spread 0.01
Spread %0.32%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.38 EUR
Average target price
39.84 EUR
Spread / Average Target
+3.81%
Consensus